Multiple myeloma: optimal management and long-term disease control
Priya Sriskandarajah, Faith E Davies Divisions of Molecular Pathology, Cancer Therapeutics, and Clinical Studies, Institute of Cancer Research, Sutton, UK Abstract: Multiple myeloma is an incurable hematological disease previously associated with poor prognosis and survival rates. However, followi...
Guardado en:
Autores principales: | Sriskandarajah P, Davies FE |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/715f124cb83c42f9956f29705311553d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
INSIGHTS INTO DIAGNOSIS AND MANAGEMENT OF ADVANCED MULTIPLE MYELOMA
por: Vasile Musteata, et al.
Publicado: (2021) -
CASE REPORT: COEXISTENCE OF CELIAC DISEASE AND MULTIPLE MYELOMA
por: Filiz YAVASOGLU, et al.
Publicado: (2021) -
Profile of elotuzumab and its potential in the treatment of multiple myeloma
por: Liu YC, et al.
Publicado: (2014) -
Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
por: Gupta VA, et al.
Publicado: (2013) -
HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
por: María-Victoria Mateos
Publicado: (2021)